A total of 91 multiply resistant bacterial strains, including Klebsiella pneumoniae (32 strains), Pseudomonas aeruginosa (16 strains), and Serratia marcescens (43 strains), were collected during hospital epidemics of nosocomial infection from 1975 to 1979. These strains were resistant to gentamicin, tobramycin, cephalothin, chloramphenicol, and ampicillin. Their susceptibility to three new broad-spectrum f-lactams, LY127935 (a 1-oxa-p-lactam), cefotaxime (HR 756), and cefoperazone (T 1551), was compared with the susceptibility of random strains of nine species of aerobic gram-negative bacilli collected in the same hospital in 1979. Susceptibility to cefamandole and ticarcillin was also determined. Strains of staphylococci and streptococci from that hospital and two nearby city-county hospitals were also compared for the three new cephalosporins and other effective antibiotics. The agar dilution method was used to measure the minimum inhibitory concentration for each antibiotic. The multiply resistant strains (minimum inhibitory concentration for gentamicin 2 8 ,ug/ml) usually were as susceptible to the three new broad-spectrum ,B-lactams as were non-multiply resistant strains.
From 1975 to 1977 either infections or colonization with multiply resistant Kiebsiella pneumoniae were found in 66 patients in a Veterans Administration hospital (3) . The epidemic has since subsided, but multiply resistant K. pneumoniae continue to be present, and increasing numbers of multiply resistant Pseudomonas aeruginosa and Serratia marcescens have been found. All three multiply resistant species have been resistant to chloramphenicol, suathiszole, cephalothin, ampicillin, gentamicin, tobramycin, neomycin, and kanamycin. The resistance in multiply resistant K. pneumoniae was found to be caused by an extrachromosomal transferable plasmid.
Since aminoglycoside antibiotics have been the mainstay of treatment of gram-negative bacillary infections, resistance to the aminoglycosides seriously compromises the antibiotic choices available in hospitals where such organisms are commonly found. The purpose of this paper is to show the in vitro activity of three new broad-spectrum ,B-lactams against a large group of these multiply resistant organisms. The three new,-lactams, including the 1-oxa-fl-lactam LY127935, cefotaxime (HR 756) , and cefoperazone (T 1551), as well as ticarcillin and cefamandole, were compared against multiply resistant gram-negative bacilli and non-multiply resistant strains of the same and other species of gram-negative bacilli. Additionally S. aureus were nearly equally susceptible to all the antibiotics tested (methicillin excepted). S. epidermidis strains, especially penicillinase-producing strains, were often less susceptible. For the latter, cefamandole and nafcillin were often more effective. For S. pyogenes and S. pneumoniae, both cefotaxime and cefoperazone were very active (equal to penicillin G and cefamandole); LY127935 was about equivalent to ticarcillin, but less effective than penicillin G. All of the new ,B-lactams (including cefamandole) were ineffective against S. faecalis. Both penicillinase-positive and -negative strains of N. gonorrhoeae were very susceptible to LY127935, cefotaxime, and cefoperazone. Ticarcillin was ineffective against penicilhinase-positive N. gonorrhoeae. Trimethoprim-sulfamethoxazole was relatively inactive both at ratios of 1:5 and 1:19, especially for peniclhinase-positive strains.
Increasing the size of the bacterial inoculum (Table 3) , especially with four of eight multiply resistant strains of enteric bacilli tested, markedly increased the MIC for LY127935, cefoperazone, and cefotaxime. The inoculum effect was less evident with cephalothin, to which the multiply resistant strains were generally highly resistant. With greater inoculum size, a methicillin-resistant strain of S. aureus was also increasingly resistant to LY127935, cefoperazone, and cefotaxime, as well as to cephalothin. The five bacterial strains given in Table 3 were selected for the greatest effect of inoculum size upon the MICs of the four /-lactams tested. There were 17 other bacterial strains examined which showed little or no inoculum effect. DISCUSSION The agar dilution method we used for the determination of antibiotic MICs was very much like that employed by others for in vitro comparisons ofLY127935 (5, 10) . Similar (2, 5, 6) . The low MIC of LY127935 against N. gonorrhoeae strains has been noted elsewhere (5, 10) ; the strong activity of cefoperazone has also been recorded (6) . Ours is the only study, however, to document their high potency for penicilinase-positive strains. The low MIC of cefotaxime for N. gonorrhoeae strains has been shown before (4, 5) . For penicihhinas-positive s;rains, the three newest.8-lactams are notably about as active as cefuroxime and cefoxitin (4 
